Atlantis China Healthcare USD

Register to Unlock Ratings
Performance History31/03/2024
Growth of 1,000 (GBP) Advanced Graph
Atlantis China Healthcare USD
Fund18.7-13.1-11.6-19.2-7.1
+/-Cat1.3-22.5-6.9-16.1-12.3
+/-B’mrk--31.3-17.4-16.6-15.1
 
Key Stats
NAV
19/04/2024
 USD 1.08
Day Change -0.36%
Morningstar Category™ Sector Equity Healthcare
ISIN IE00B1WL3F32
Fund Size (Mil)
18/04/2024
 USD 11.46
Share Class Size (Mil)
18/04/2024
 USD 11.43
Max Initial Charge -
Ongoing Charge
09/02/2022
  1.56%
Investment Objective: Atlantis China Healthcare USD
The objective of the fund is to achieve long term capital appreciation through an actively managed portfolio of equity and equity related securities issued by companies listed on recognised exchanges in Hong Kong, the People’s Republic of China, Singapore, the United States and the United Kingdom, principally engaged in pharmaceutical, bio-technology, medical devices, healthcare provision and ownership or management of hospitals/nursing homes, health maintenance organisations or in other health related industries .
Returns
Trailing Returns (GBP)19/04/2024
YTD-6.79
3 Years Annualised-15.63
5 Years Annualised-6.90
10 Years Annualised-2.61
12 Month Yield 0.00
Dividend Paying Frequency Annually
Management
Manager Name
Start Date
Yan Yang
01/01/2018
Inception Date
19/06/2007
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
Hang Seng HSI GR USDMorningstar Gbl Health TME NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNo
HedgingNo
OtherNot Specific
Portfolio Profile for  Atlantis China Healthcare USD-
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Top 5 Regions%
No Data Available
Top 5 Sectors%
No Data Available
Top 5 HoldingsSector%
No Data Available
Atlantis China Healthcare USD

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures